{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:07:01Z","timestamp":1792058821395,"version":"4.4.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004595","name":"Universiti Sains Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>An increase in the occurrence of viral infectious diseases is a global concern for human health. According to a WHO report, dengue virus (DENV) is one of the most common viral diseases affecting approximately 400 million people annually, with worsening symptoms in nearly 1% of cases. Both academic and industrial researchers have conducted numerous studies on viral epidemiology, virus structure and function, source and route of infection, treatment targets, vaccines, and drugs. The development of CYD-TDV or Dengvaxia<jats:sup>\u00ae<\/jats:sup>vaccine has been a major milestone in dengue treatment. However, evidence has shown that vaccines have some drawbacks and limitations. Therefore, researchers are developing dengue antivirals to curb infections. DENV NS2B\/NS3 protease is a DENV enzyme essential for replication and virus assembly, making it an interesting antiviral target. For faster hit and lead recognition of DENV targets, methods to screen large number of molecules at lower costs are essential. Similarly, an integrated and multidisciplinary approach involving<jats:italic>in silico<\/jats:italic>screening and confirmation of biological activity is required. In this review, we discuss recent strategies for searching for novel DENV NS2B\/NS3 protease inhibitors from the<jats:italic>in silico<\/jats:italic>and<jats:italic>in vitro<\/jats:italic>perspectives, either by applying one of the approaches or by integrating both. Therefore, we hope that our review will encourage researchers to integrate the best strategies and encourage further developments in this area.<\/jats:p>","DOI":"10.3389\/fcimb.2023.1061937","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:51:55Z","timestamp":1676393515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Assessing the potential of NS2B\/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach"],"prefix":"10.3389","volume":"13","author":[{"given":"Harun","family":"Norshidah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiuan Herng","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamarulzaman Ezatul","family":"Ezleen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habibah A.","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran","family":"Vignesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Rasul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngit Shin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.7150\/ijms.29938","article-title":"The conserved molecular determinants of virulence in dengue virus","volume":"16","author":"Ahmad","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.866452","article-title":"In vitro antiviral activity of potential medicinal plant extracts against dengue and chikungunya viruses","volume":"12","author":"Alagarasu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/v12040367","article-title":"Structure-based design of antivirals against envelope glycoprotein of dengue virus","volume":"12","author":"Anasir","year":"2020","journal-title":"In Viruses"},{"key":"B4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.antiviral.2018.12.002","article-title":"Inhibition of dengue virus by curcuminoids","volume":"162","author":"Balasubramanian","year":"2019","journal-title":"Antiviral Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.antiviral.2013.06.001","article-title":"Development of specific dengue virus 2\u2019-o- and N7-methyltransferase assays for antiviral drug screening","volume":"99","author":"Barral","year":"2013","journal-title":"Antiviral Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbrc.2014.09.113","article-title":"Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format","volume":"453","author":"Basavannacharya","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.virol.2016.12.004","article-title":"The calmodulin antagonist W-7 (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride) inhibits DENV infection in huh-7 cells","volume":"501","author":"Bautista-Carbajal","year":"2017","journal-title":"Virology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0042-6822(89)90639-9","article-title":"Detection of a trypsin-like serine protease domain in flaviviruses and pestviruses","volume":"171","author":"Bazan","year":"1989","journal-title":"Virology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3851\/IMP3231","article-title":"A quinoline compound inhibits the replication of dengue virus serotypes 1\u20134 in vero cells","volume":"23","author":"Beesetti","year":"2018","journal-title":"Antiviral Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-55723-5","article-title":"Discovery of ganoderma lucidum triterpenoids as potential inhibitors against dengue virus NS2B-NS3 protease","volume":"9","author":"Bharadwaj","year":"2019","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.2838","article-title":"Structure-guided screening of chemical database to identify NS3-NS2B inhibitors for effective therapeutic application in dengue infection","volume":"33","author":"Bhowmick","year":"2020","journal-title":"J. Mol. Recognit."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006411","article-title":"A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease","volume":"13","author":"Brecher","year":"2017","journal-title":"PloS Pathog."},{"key":"B13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejmech.2015.12.030","article-title":"Discovery of antiviral molecules for dengue: In silico search and biological evaluation","volume":"110","author":"Cabarcas-Montalvo","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1128\/jvi.65.11.6042-6050.1991","article-title":"Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites","volume":"65","author":"Chambers","year":"1991","journal-title":"J. Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.5958\/0974-360X.2019.01017.5","article-title":"Docking of phytoconstituents of cynodon dactylon on NS2B NS3 protease domain of dengue virus","volume":"12","author":"Chandani","year":"2019","journal-title":"Res. J. Pharm. Technol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1128\/jvi.02044-09","article-title":"Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family","volume":"84","author":"Chandramouli","year":"2010","journal-title":"J. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.antiviral.2015.03.010","article-title":"Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay","volume":"118","author":"Chu Lee","year":"2015","journal-title":"Antiviral Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1016\/j.bmc.2019.07.038","article-title":"Peptide derivatives as inhibitors of NS2B-NS3 protease from dengue, West Nile, and zika flaviviruses","volume":"27","author":"da Silva-J\u00fanior","year":"2019","journal-title":"Bioorg. Medicinal Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijantimicag.2008.10.010","article-title":"Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV","volume":"33","author":"De Clercq","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12864-021-07638-7\/FIGURES\/8","article-title":"Structural landscape of the complete genomes of dengue virus serotypes and other viral hemorrhagic fevers","volume":"22","author":"Delli Ponti","year":"2021","journal-title":"BMC Genomics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.bmc.2014.12.015","article-title":"Flavonoids as noncompetitive inhibitors of dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies","volume":"23","author":"de Sousa Wu","year":"2015","journal-title":"Bioorg. Medicinal Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1080\/07391102.2020.1734485","article-title":"Anti-dengue infectivity evaluation of bioflavonoid from azadirachta indica by dengue virus serine protease inhibition","volume":"39","author":"Dhar Dwivedi","year":"2020","journal-title":"J. Biomol. Struct Dynamics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1021\/acs.jmedchem.9b00759","article-title":"Peptide-\u03b2-lactam inhibitors of dengue and West Nile virus NS2B-NS3 protease display two distinct binding modes","volume":"63","author":"Dra\u017ei\u0107","year":"2020","journal-title":"J. Medicinal Chem."},{"key":"B24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/0972-9062.184848","article-title":"In silico evaluation of inhibitory potential of triterpenoids from azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease","volume":"53","author":"Dwivedi","year":"2016","journal-title":"J. Vector Borne Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","article-title":"An RNA cap (nucleoside-2\u2032-O-) -methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization","volume":"21","author":"Egloff Benarroch","year":"2002","journal-title":"EMBO J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2323\/jgam.2018.10.001","article-title":"In vitro antiviral activity of spirotetronate compounds against dengue virus serotype 2","volume":"65","author":"Euanorasetr","year":"2019","journal-title":"J. Gen. Appl. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1128\/jvi.65.5.2467-2475.1991","article-title":"Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins","volume":"65","author":"Falgout","year":"1991","journal-title":"J. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.36721\/PJPS.2020.33.1.SUP.355-360.1","article-title":"Exploration of carica papaya bioactive compounds as potential inhibitors of dengue NS2B, NS3 and NS5 protease","author":"Farooq","year":"2020","journal-title":"Pakistan J. Pharm. Sci."},{"key":"B30","first-page":"32351","volume-title":"Guidance for industry antiviral product development\u2013conducting and submitting virology studies to the agency","year":"2006"},{"key":"B31","first-page":"264","article-title":"Molecular docking and pharmacokinetics study for selected leaf phytochemicals from carica papaya linn. against dengue virus protein, NS2B\/NS3 protease","volume":"124","author":"Ghosh","year":"2019","journal-title":"World Sci. News"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1021\/acs.biochem.7b01127","article-title":"Inhibitor bound dengue NS2B-NS3pro reveals multiple dynamic binding modes","volume":"57","author":"Gibbs","year":"2018","journal-title":"Biochemistry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication. annual reviews in microbiology","volume":"44","author":"Hahn","year":"1990","journal-title":"Annu. Rev. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0210869","article-title":"Thioguanine-based DENV-2 NS2B\/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling","volume":"14","author":"Hariono","year":"2019","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"31235","DOI":"10.1039\/C6RA00817H","article-title":"In silico study on baicalein and baicalin as inhibitors of dengue virus replication","volume":"6","author":"Hassandarvish","year":"2016","journal-title":"RSC Adv."},{"key":"B36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2174\/0929867325666180629124709","article-title":"Latest updates in dengue fever therapeutics: Natural, marine and synthetic drugs","volume":"27","author":"Hosseini","year":"2018","journal-title":"Curr. Medicinal Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1479-0556-10-6","article-title":"A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan","volume":"10","author":"Idrees","year":"2012","journal-title":"Genet. Vaccines Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.14499\/indonesianjpharm30iss2pp84-90","article-title":"Synthesis and in silico studies of a benzenesulfonyl curcumin analogue as a new anti-dengue virus type 2 (DEN2) NS2B\/NS3","volume":"30","author":"Ikhtiarudin","year":"2019","journal-title":"Indonesian J. Pharm."},{"key":"B39","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/1574893615666191219094216","article-title":"Relevance of molecular docking studies in drug designing","volume":"15","author":"Jakhar","year":"2019","journal-title":"Curr. Bioinf."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.3390\/molecules23071678","article-title":"Microwave optimized synthesis of n-(adamantan-1-yl)-4-[(adamantan-1-yl)-sulfamoyl] benzamide and its derivatives for anti-dengue virus activity","volume":"23","author":"Joubert","year":"2018","journal-title":"Molecules"},{"key":"B41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/bs.apcsb.2019.11.013","article-title":"Computational approaches for identifying potential inhibitors on targeting protein interactions in drug discovery","volume":"121","author":"Kanakaveti","year":"2020","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1126\/SCIENCE.ABK0058","article-title":"Antigenic evolution of dengue viruses over 20 years","volume":"374","author":"Katzelnick","year":"2021","journal-title":"Sci. (New York N.Y.)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1016\/j.bmcl.2005.12.075","article-title":"Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease","volume":"16","author":"Kiat","year":"2006","journal-title":"Bioorg. Medicinal Chem. Lett."},{"key":"B44","first-page":"165","article-title":"Biotechnological application of health promising bioactive molecules","volume-title":"Biotechnological production of bioactive compounds","author":"Kumar","year":"2019"},{"key":"B45","first-page":"1","article-title":"Synthetic approaches toward small molecule libraries","volume-title":"Small molecule drug discovery: Methods, molecules and applications","author":"Lenci","year":"2019"},{"key":"B46","doi-asserted-by":"publisher","first-page":"45762","DOI":"10.1074\/jbc.M107360200","article-title":"Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B Co-factor, small peptide substrates, and inhibitors","volume":"276","author":"Leung","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1038\/emi.2015.18","article-title":"Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control","volume":"4","author":"Liang Gao","year":"2015","journal-title":"Emerg. Microbes Infect."},{"key":"B48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/cbdd.12500","article-title":"Structure-guided discovery of a novel non-peptide inhibitor of dengue virus NS2B-NS3 protease","volume":"86","author":"Li","year":"2015","journal-title":"Chem. Biol. Drug Design"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1128\/jvi.73.4.3108-3116.1999","article-title":"The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids","volume":"73","author":"Li","year":"1999","journal-title":"J. Virol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"28766","DOI":"10.1074\/jbc.M500588200","article-title":"Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","article-title":"Dengue drug discovery: Progress, challenges and outlook","volume":"163","author":"Lim","year":"2019","journal-title":"Antiviral Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1080\/07391102.2019.1678523","article-title":"The identification of active compounds in ganoderma lucidum var. antler extract inhibiting dengue virus serine protease and its computational studies","volume":"38","author":"Lim","year":"2020","journal-title":"J. Biomol. Struct Dynamics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"31105","DOI":"10.1074\/jbc.M113.508606","article-title":"A crystal structure of the dengue virus non-structural protein 5 (NS5) polymerase delineates interdomain amino acid residues that enhance its thermostability and de novo initiation activities","volume":"288","author":"Lim","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2105-12-S13-S24","article-title":"Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus","volume":"12","author":"Lim","year":"2011","journal-title":"BMC Bioinf."},{"key":"B55","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.antiviral.2008.08.005","article-title":"A scintillation proximity assay for dengue virus NS5 2\u2032-o-methyltransferase-kinetic and inhibition analyses","volume":"80","author":"Lim","year":"2008","journal-title":"Antiviral Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","article-title":"Erythrosin b is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease","volume":"150","author":"Li","year":"2018","journal-title":"Antiviral Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1016\/j.bmc.2014.09.057","article-title":"Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B\/NS3 protease","volume":"22","author":"Liu","year":"2014","journal-title":"Bioorg. Medicinal Chem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-981-10-8727-1_22","article-title":"Dengue antiviral development: A continuing journey. in dengue and zika: Control and antiviral treatment strategies","author":"Low Gatsinga","year":"2018","journal-title":"Springer Singapore"},{"key":"B59","doi-asserted-by":"publisher","first-page":"18817","DOI":"10.1074\/jbc.M109.090936","article-title":"Flexibility between the protease and helicase domains of the dengue virus NS3 protein conferred by the linker region and its functional implications","volume":"285","author":"Luo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1128\/jvi.01788-07","article-title":"Crystal structure of the NS3 protease-helicase from dengue virus","volume":"82","author":"Luo","year":"2008","journal-title":"J. Virol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrd4050","article-title":"Novel therapies for hepatitis c\u2013one pill fits all","volume":"12","author":"Manns","year":"2013","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B62","doi-asserted-by":"publisher","first-page":"191","DOI":"10.21315\/jps2019.30.s2.16","article-title":"The in-silico studies of benzylidene indanone derivatives towards dengue virus type-2 NS2B\/NS3 protease","volume":"30","author":"Nesfu","year":"2019","journal-title":"J. Phys. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1128\/JVI.02451-09","article-title":"Inhibition of dengue virus polymerase by blocking of the RNA tunnel","volume":"84","author":"Niyomrattanakit","year":"2010","journal-title":"J. Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.antiviral.2015.04.007","article-title":"Stabilization of dengue virus polymerase in de novo initiation assay provides advantages for compound screening","volume":"119","author":"Niyomrattanakit","year":"2015","journal-title":"Antiviral Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1128\/jvi.06225-11","article-title":"Ligand-bound structures of the dengue virus protease reveal the active conformation","volume":"86","author":"Noble","year":"2012","journal-title":"J. Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"8831","DOI":"10.1128\/jvi.77.16.8831-8842.2003","article-title":"De novo synthesis of negative-strand RNA by dengue virus RNA-dependent RNA polymerase In vitro: Nucleotide, primer, and template parameters","volume":"77","author":"Nomaguchi","year":"2003","journal-title":"J. Virol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.5935\/0103-5053.20140057","article-title":"NS3 and NS5 proteins: important targets for anti-dengue drug design","volume":"25","author":"Oliveira Silva","year":"2014","journal-title":"J. Braz. Chem. Soc."},{"key":"B68","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.apsb.2017.04.009","article-title":"3, 5-bis (arylidene)-4-piperidones as potential dengue protease inhibitors","volume":"7","author":"Osman Idris","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.17576\/jsm-2017-4610-25","article-title":"Molecular docking studies of selected medicinal drugs as dengue virus-2 protease inhibitors","volume":"46","author":"Othman","year":"2017","journal-title":"Sains Malaysiana"},{"key":"B70","first-page":"215","article-title":"Analysis of secondary structure predictions of dengue virus type 2 NS2B\/NS3 against crystal structure to evaluate the predictive power of the in-silico methods","volume":"7","author":"Othman","year":"2007","journal-title":"In Silico Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actatropica.2018.08.022","article-title":"Development of antiviral inhibitor against dengue 2 targeting Ns3 protein: In vitro and in silico significant studies","volume":"188","author":"Padmapriya","year":"2018","journal-title":"Acta Trop."},{"key":"B72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jviromet.2014.08.023","article-title":"Isolation and propagation of dengue virus in vero and BHK-21 cells expressing human DC-SIGN stably","volume":"209","author":"Phanthanawiboon","year":"2014","journal-title":"J. Virol. Methods"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.3390\/ijms22062879","article-title":"Cytokine signature of dengue patients at different severity of the disease","volume":"22","author":"Puc","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B74","first-page":"2119","article-title":"In-silico identification and evaluation of plant flavonoids as dengue NS2B\/NS3 protease inhibitors using molecular docking and simulation approach","volume":"30","author":"Qamar","year":"2017","journal-title":"Pak. J. Pharm. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3923\/ijp.2016.621.632","article-title":"Discovery of novel dengue NS2B\/NS3 protease inhibitors using pharmacophore modeling and molecular docking based virtual screening of the zinc database","volume":"12","author":"Qamar","year":"2016","journal-title":"Int. J. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1515\/tjb-2018-0002","article-title":"Computational exploration of antiviral activity of phytochemicals against NS2B\/NS3 proteases from dengue virus","volume":"44","author":"Rasool","year":"2018","journal-title":"Turkish J. Biochem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12985-015-0248-x","article-title":"A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture","volume":"12","author":"Raut","year":"2015","journal-title":"Virol. J."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12985-015-0248-X","article-title":"A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture","volume":"12","author":"Raut","year":"2015","journal-title":"Virol. J."},{"key":"B79","first-page":"e2101","article-title":"Dengue: Status of current and under-development vaccines","volume-title":"Reviews in medical virology","author":"Redoni","year":"2020"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1021\/acsomega.8b02861","article-title":"Inhibition of dengue virus protease by eugeniin, isobiflorin, and biflorin isolated from the flower buds of syzygium aromaticum (Cloves)","volume":"4","author":"Saleem","year":"2019","journal-title":"ACS Omega"},{"key":"B81","first-page":"357","article-title":"Dengue protease inhibition activity of selected Malaysian medicinal herbs","volume":"36","author":"Salleh","year":"2019","journal-title":"Trop. Biomed."},{"key":"B82","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12900-018-0084-5","article-title":"Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease","volume":"18","author":"Sarwar","year":"2018","journal-title":"BMC Struct. Biol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.virol.2006.03.026","article-title":"Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA-dependent RNA polymerases","volume":"351","author":"Selisko","year":"2006","journal-title":"Virology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/microorganisms9030545","article-title":"Structure-based virtual screening: identification of a novel NS2B-NS3 protease inhibitor with potent antiviral activity against Zika and Dengue viruses","volume":"9","author":"Shin","year":"2021","journal-title":"Microorganisms"},{"key":"B85","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0958-1669(00)00177-4","article-title":"Cytotoxicity tests for high-throughput drug discovery","volume":"12","author":"Slater","year":"2001","journal-title":"Curr. Opin. Biotechnol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/V14040703\/S1","article-title":"Global evolutionary history and dynamics of dengue viruses inferred from whole genome sequences","volume":"14","author":"Stica","year":"2022","journal-title":"Viruses"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1934578X19861014","DOI":"10.1177\/1934578X19861014","article-title":"Chemical constituents from endiandra kingiana (Lauraceae) as potential inhibitors for dengue type 2 NS2B\/NS3 serine protease and its molecular docking","volume":"14","author":"Sulaiman","year":"2019","journal-title":"Natural Product Commun."},{"key":"B88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.37358\/RC.19.9.7555","article-title":"In silico docking study of some coumarin derivatives as potential inhibitors on different dengue viral proteins","volume":"10","author":"Tataringa","year":"2019","journal-title":"Proteins (NS1 NS2A NS2B NS3 NS4A NS4B NS5)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/TRSTMH\/TRAA007","article-title":"Persistence of symptoms in dengue patients: A clinical cohort study","volume":"114","author":"Tiga-Loza","year":"2021","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1177\/25151355211015839","article-title":"Dengvaxia: the world\u2019s first vaccine for prevention of secondary dengue","volume":"9","author":"Tully","year":"2021","journal-title":"Ther. Adv. Vaccines Immunother."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-38450-1","article-title":"Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus","volume":"9","author":"ul Qamar","year":"2019","journal-title":"Sci. Rep."},{"key":"B92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-018-0168-0","article-title":"Dengue virus and the host innate immune response","volume":"7","author":"Uno","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1021\/ci500531r","article-title":"Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery web portal","volume":"54","author":"Viswanathan","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"B94","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.febslet.2009.01.008","article-title":"Analysis of the nucleoside triphosphatase, RNA triphosphatase, and unwinding activities of the helicase domain of dengue virus NS3 protein","volume":"583","author":"Wang","year":"2009","journal-title":"FEBS Lett."},{"key":"B95","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1128\/jvi.67.2.989-996.1993","article-title":"RNA-Stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria","volume":"67","author":"Warrener","year":"1993","journal-title":"J. Virol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0042-6822(91)90440-M","article-title":"The carboxy-terminal part of the NS 3 protein of the West Nile flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase","volume":"184","author":"Wengler","year":"1991","journal-title":"Virology"},{"key":"B97","volume-title":"Dengue and severe dengue","year":"2022"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1128\/AAC.03543-14","article-title":"Novel dengue virus NS2B\/NS3 protease inhibitors","volume":"59","author":"Wu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B99","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2015.03.007","article-title":"Targeting dengue virus NS4B protein for drug discovery","volume":"118","author":"Xie Zou","year":"2015","journal-title":"Antiviral Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejphar.2017.12.029","article-title":"Inhibition of dengue viral infection by diasarone-I is associated with 2\u2019O methyltransferase of NS5","volume":"821","author":"Yao","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1021\/cb400612h","article-title":"Allosteric inhibition of the NS2B-NS3 protease from dengue virus","volume":"8","author":"Yildiz","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bmcl.2005.09.062","article-title":"Peptide inhibitors of dengue virus NS3 protease.Part 1: Warhead","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B103","doi-asserted-by":"publisher","first-page":"9963","DOI":"10.1074\/jbc.275.14.9963","article-title":"Purified NS2B\/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro","volume":"275","author":"Yusof","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B104","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13065-018-0435-0","article-title":"4-thiazolidinone coumarin derivatives as two-component NS2B\/NS3 DENV flavivirus serine protease inhibitors: synthesis, molecular docking, biological evaluation and structure\u2013activity relationship studies","volume":"12","author":"Yusufzai","year":"2018","journal-title":"Chem. Cent. J."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00044-018-2179-8","article-title":"Synthesis, X-ray crystallographic study, pharmacology and docking of hydrazinyl thiazolyl coumarins as dengue virus NS2B\/NS3 serine protease inhibitors","volume":"27","author":"Yusufzai","year":"2018","journal-title":"Medicinal Chem. Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"M1088","DOI":"10.3390\/M1088","article-title":"3-(3, 4-Dimethoxyphenyl)-5-(2-fluorophenyl)-1-phenyl-4, 5-dihydro-1H-pyrazole","volume":"2019","author":"Zamri","year":"2019","journal-title":"Molbank"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004682","article-title":"A crystal structure of the dengue virus NS5 protein reveals a novel inter-domain interface essential for protein flexibility and virus replication","volume":"11","author":"Zhao","year":"2015","journal-title":"PloS Pathog."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1061937\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T06:50:03Z","timestamp":1728888603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1061937\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":107,"alternative-id":["10.3389\/fcimb.2023.1061937"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1061937","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"article-number":"1061937"}}